Journals / Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi / 2007 / Cilt: 53 - Sayı: 4

Intra-articular hyaluronic acid in the management of osteoarthritis

Osteoartritte intraartiküler hyalüronik asit tedavisi

Pages
154–159
Publication Date
2022-11-03
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

HA is recommended in the knee OA treatment in a lot of guidelines published in USA and Europe.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Osteoarthritis (OA) is the most common chronic joint disease in the world.
📊
Key Findings & Data:Pain and functional recovery rank is 1b evidence level with HA management in knee OA according to evidence-based medicine methodology.
💡
Conclusion & Impact:HA is recommended in the knee OA treatment in a lot of guidelines published in USA and Europe.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Osteoarthritis (OA) is the most common chronic joint disease in the world. Intra-articular hyaluronic acid (HA) managements have been pervading increasingly in the OA treatment. But many physicians have still plenty of questions about this method. In this article, intra-articular HA management in OA treatment was reviewed in the light of clinic investigations. Actually there are many researches about this subject. Pain and functional recovery rank is 1b evidence level with HA management in knee OA according to evidence-based medicine methodology. HA is recommended in the knee OA treatment in a lot of guidelines published in USA and Europe. First and the most common application area is knee joint. Carrying out for other joints are hopeful but we need more quality studies about this topic. Although there are opposite point of views, many in-vitro studies are constructive and, effectiveness of HA managements beyond the placebo was shown with in-vivo controlled clinic studies. To state whether the treatment is effective or not, application must be done on patients chosen properly and findings must be evaluated objectively. Pseudoseptic reaction is the most seen side effect. This local effect is temporary and in general it is relation with the injection technique.

Özet

Osteoartrit (OA) dünya üzerinde en sık rastlanan kronik eklem hastalığıdır. OA tedavisinde intraartiküler hyalüronik asit (HA) uygulamaları giderek yaygınlaşmaktadır. Ancak bu tedavi yöntemi hakkında pek çok hekimin kafasında hala bir takım sorular mevcuttur. Bu yazıda yapılan klinik araştırmaların ışığında OA tedavisinde intraartiküler HA uygulamalarının yeri gözden geçirilmiştir. Bu konuda yapılmış çok sayıda araştırma mevcuttur. Diz OA’sında HA’ların ağrı ve fonksiyonel düzelme açısından kanıta dayalı tıp metodolojisine göre kanıt düzeyi 1b’dir. Amerika Birleşik Devletleri’nde ve Avrupa’da yayınlanan pek çok tedavi klavuzunda diz OA tedavisinde önerilmektedir. İlk ve en sık kullanıldığı eklem diz eklemidir. Diğer eklemlere yapılacak uygulamalar da ümit vaad etmektedir ancak bu konuda çalışmalara ihtiyaç vardır. Her ne kadar karşıt görüşler olsa da yapılan çok sayıda in-vitro çalışma olumludur ve in-vivo kontrollü klinik çalışmalar ile diz OA’sında intraartiküler HA uygulamalarının plaseboya üstünlüğü gösterilmiştir. Tedavinin etkin olup olmadığını söyleyebilmek için doğru seçilmiş hastalar üzerinde uygulama yapılmalı ve bulgular değerlendirilmelidir. İstenmeyen etkiler arasında en sık görüleni psödoseptik reaksiyondur. Bu lokal etki geçicidir ve çoğunlukla enjeksiyon tekniği ile ilişkilidir.

🔖

Cite This Article

DIRAÇOĞLU, D. (2022). Intra-articular hyaluronic acid in the management of osteoarthritis. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, Cilt: 53 - Sayı: 4, 154–159. https://ajindex.com/articles/629172

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ettinger WH, Burns R, Messier SP, Applegate W, Rejeski WJ, Morgan T, et al. A randomised trial comparing aerobic exercise and resistance exercise with a health education program in older adults with knee osteoarthritis. JAMA 1997;277:25-31
  2. Dieppe PA, Buckwalter JA. Management of limb joint osteoarthritis. Osteoarthritis and related disorders. In: Klippel JH, Dieppe PA. (Eds) Rheumatology, Second Edition. London: Mosby; 1998. p. 8.9.3
  3. Pap G, Machner A, Awiszus F. Measuring knee joint kinesthesis for determining proprioceptive deficits in varus gonarthrosis. Z Rheumatol 1998;57:5-10
  4. Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hyalan, a hyaluronan derivative. Exp Brain Res 1997;116:3-9
  5. Griffin LY. (Ed) Complementary and alternative therapies for osteoarthritis in essentials of musculoskeletal care. Third Ed. American Academy of Orthopaedic Surgeons. Rosemont IL 2005. p. 91-2
  6. Neustadt DH. Intra-Articular injections for osteoarthritis of the knee. Cleve Clin J Med 2006;73:897-8, 901-4, 906-11
  7. Kelly MA, Moskowitz RW, Lieberman JR. Hyaluronan therapy: looking toward the future. Am J Orthop 2004;33(2 Suppl):23-8
  8. Yagishita K, Sekiya I, Sakaguchi Y, Shinomiya K, Muneta T. The effect of hyaluronan on tendon healing in rabbits. Arthroscopy 2005;21:1330-6
  9. Tanaka T, Sun YL, Zhao C, Zobitz ME, An KN, Amadio PC. Optimization of surface modifications of extrasynovial tendon to improve its gliding ability in a canine model in vitro. J Orthop Res 2006;24:1555-61
  10. Voinchet V, Vasseur P, Kern J. Efficacy and safety of hyaluronic acid in the management of acute wounds. Am J Clin Dermatol 2006;7:353-7
  11. Kobelt G, Fianu-Jonasson A. Treatment of stress urinary incontinence with non-animal stabilised hyaluronic acid/dextranomer (NASHA/Dx) gel: An analysis of utility and cost. Clin Drug Investig 2006;26:583-91
  12. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Müllner M. Intraarticular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005;172:1039-43
  13. Dagenais S. Intra-articular hyaluronic acid (viscosupplementation) for knee osteoarthritis. Issues Emerg Health Technol 2006;94:1-4
  14. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update. Arthritis Rheum 2000;43:1905-15
  15. Jordan KM, Arden